Skip to main content
logo
Newbury Pharmaceuticals AB (publ) (STO:NEWBRY)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.600
+0.110 (4.42%)
Jul 24, 2026, 5:23 PM CET

STO:NEWBRY Financials Overview

Millions SEK. Fiscal year is Sep - Aug.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Revenue
36.6334.2139.7411.177.242.84
Revenue Growth
-26.31%-13.91%255.77%54.27%154.93%-
Gross Profit
11.2315.4618.944.853.290.47
Operating Income
-24.79-21.97-14.08-19.59-14.67-5.62
Net Income
-26.91-23.88-15.41-19.43-14.67-5.56
Earnings Per Share
-0.80-0.78-0.63-0.98-0.75-0.35
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Net Cash (Debt)
14.6814.5615.38.5333.3313.15
Net Cash Growth
25.76%-4.84%79.44%-74.42%153.58%-
Cash & Investments
14.6814.5615.38.5333.3313.15
Net Cash Per Share
0.440.470.620.431.700.84

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Operating Cash Flow
-19.58-12.37-23.71-23.23-15-4.07
Free Cash Flow
-19.58-12.37-23.71-23.23-15-4.07
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Gross Margin
30.66%45.20%47.66%43.43%45.41%16.58%
Operating Margin
-67.66%-64.21%-35.43%-175.37%-202.58%-197.92%
Pretax Margin
-72.69%-69.00%-38.78%-173.97%-202.58%-195.67%
Profit Margin
-71.90%-68.18%-38.79%-173.97%-202.58%-195.67%
FCF Margin
-53.45%-36.16%-59.66%-207.96%-207.20%-143.17%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Aug '25 Aug '24 Aug '23 Aug '22 Aug '21
Forward PE
-13.45----
PS Ratio
2.261.852.016.9910.56-